More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Pure Liquid Flavored Trio

Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Pure Liquid Flavored Trio

by adminAdrianRamirez | Nov 21, 2018 | Kannaway, Press Releases

SAN DIEGO, Nov. 21, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first-ever publicly traded cannabis company in the United States, today announced that its subsidiary Kannaway® has released its new hemp-based CBD (cannabidiol) Kannaway® Pure Liquid Flavored...
Medical Marijuana, Inc. Subsidiary HempMeds® Launches New 2 oz. Green Label Liquid RSHO™ and 2 oz. Gold Label Liquid RSHO™

Medical Marijuana, Inc. Subsidiary HempMeds® Launches New 2 oz. Green Label Liquid RSHO™ and 2 oz. Gold Label Liquid RSHO™

by adminAdrianRamirez | Nov 19, 2018 | HempMeds

SAN DIEGO, Nov. 19, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, subsidiary HempMeds® announced today the release of two new liquid hemp products: Real Scientific Hemp Oil™ (RSHO™) Green Label...
Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Release of New Flavored CBD Vape Liquids

Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces Release of New Flavored CBD Vape Liquids

by adminAdrianRamirez | Nov 15, 2018 | Dixie Botanicals, Press Releases

SAN DIEGO, Nov. 15, 2018 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary Dixie Botanicals® has released a new line of flavored cannabidiol (CBD) vaporizer (vape) liquids....
Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Opens New Office in São Paulo

Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Opens New Office in São Paulo

by adminAdrianRamirez | Nov 14, 2018 | HempMeds Brasil, Press Releases

SAN DIEGO, Nov. 20, 2018 — Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brasil opened its newest office in São Paulo on Nov. 13, 2018. “We were very...
Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Grand Opening in Prague

Medical Marijuana, Inc. Subsidiary Kannaway® Announces European Grand Opening in Prague

by adminAdrianRamirez | Nov 14, 2018 | Kannaway, Press Releases

SAN DIEGO, Nov. 14, 2018 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway®, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is holding its official European Grand Opening in Prague on Nov....
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.